Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Demographic characteristics and differential analysis of the training set population. Variables | Total (n = 86) | Treatment-effective (n = 20) | Treatment-highly-effective (n = 66) | Statistic | p: Vitamin D, Mean ± SD | 21.87 ± 8.13 | 20.04 ± 5.96 | 22.41 ± 8.64 | t = −1.02 | 0.310

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This was a retrospective cohort study including 400 children diagnosed with short stature.

Source: Abstract.

Patients were divided into three groups: growth hormone intervention group, nutritional support group, and untreated (watchful waiting) group, based on parental choice after clinical evaluation.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Population characteristics of children with short stature and construction of a predictive model for growth hormone treatment efficacy

Cohort study · Frontiers in Medicine · 2026

Original publication title

Population characteristics of children with short stature and construction of a predictive model for growth hormone treatment efficacy

Chuanwei Ban; Juan Wang; Qian Zeng; Ping Liu; Xin Lv

Copyright © 2026 Ban, Wang, Zeng, Liu and Lv.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This study confirms that growth hormone treatment improves growth velocity in children with short stature. A predictive model was established and internally validated. Since treatment duration was the significant predictor and is observed during treatment, the model is more suitable for intra-treatment efficacy evaluation rather than pure pre-treatment decision-making. This model has the potential to support clinicians with individualized dynamic efficacy assessment and subsequent patient management, facilitating the optimization of follow-up treatment regimens.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

This study aims to analyze clinical characteristics and treatment patterns among children with short stature, and to develop a predictive model for growth hormone treatment efficacy for clinical reference.

Source: Background

Abstract: What methods does the paper describe?

This was a retrospective cohort study including 400 children diagnosed with short stature. Patients were divided into three groups: growth hormone intervention group, nutritional support group, and untreated (watchful waiting) group, based on parental choice after clinical evaluation. Annualized growth velocity was compared between the growth hormone intervention and nutritional support groups. Within the growth hormone intervention group, 70% of subjects were randomly assigned to a training set and 30% to an internal validation set. Multivariate logistic regression was used to identify factors associated with growth hormone treatment efficacy.

A nomogram prediction model was constructed and evaluated using receiver operating characteristic (ROC) curves, calibration curves, Hosmer-Lemeshow test, and decision curve analysis.

Source: Methods

Abstract: Results

A total of 293 children were included after excluding 107 cases (76 with missing data, 11 with skeletal dysplasia, 16 with hypothyroidism, 4 with chromosomal abnormalities). The growth hormone intervention group (n = 124) showed significantly higher annualized growth velocity than the nutritional support group (n = 124) across all age groups (p < 0.05). Multivariate logistic regression revealed that duration of growth hormone therapy was the independent predictor of treatment efficacy (OR = 4.45, 95% CI: 1.53 to 12.93, p = 0.006).

Six variables (treatment duration, age at initiation, insulin-like growth factor-1 (IGF-1), target height, baseline height, gender) were included in the nomogram model. The model showed good discrimination [area under the curve (AUC) = 0.88 in training set, 95% confidence interval (CI): 0.80 to 0.96; AUC = 0.85 in validation set, 95% CI: 0.69 to 1.00], good calibration, and favorable clinical net benefit.

Source: Results

Abstract: Conclusion

This study confirms that growth hormone treatment improves growth velocity in children with short stature. A predictive model was established and internally validated. Since treatment duration was the significant predictor and is observed during treatment, the model is more suitable for intra-treatment efficacy evaluation rather than pure pre-treatment decision-making. This model has the potential to support clinicians with individualized dynamic efficacy assessment and subsequent patient management, facilitating the optimization of follow-up treatment regimens.

Source: Conclusion
Authors’ abstract

Background

This study aims to analyze clinical characteristics and treatment patterns among children with short stature, and to develop a predictive model for growth hormone treatment efficacy for clinical reference.

Methods

This was a retrospective cohort study including 400 children diagnosed with short stature. Patients were divided into three groups: growth hormone intervention group, nutritional support group, and untreated (watchful waiting) group, based on parental choice after clinical evaluation. Annualized growth velocity was compared between the growth hormone intervention and nutritional support groups. Within the growth hormone intervention group, 70% of subjects were randomly assigned to a training set and 30% to an internal validation set. Multivariate logistic regression was used to identify factors associated with growth hormone treatment efficacy.

A nomogram prediction model was constructed and evaluated using receiver operating characteristic (ROC) curves, calibration curves, Hosmer-Lemeshow test, and decision curve analysis.

Results

A total of 293 children were included after excluding 107 cases (76 with missing data, 11 with skeletal dysplasia, 16 with hypothyroidism, 4 with chromosomal abnormalities). The growth hormone intervention group (n = 124) showed significantly higher annualized growth velocity than the nutritional support group (n = 124) across all age groups (p < 0.05). Multivariate logistic regression revealed that duration of growth hormone therapy was the independent predictor of treatment efficacy (OR = 4.45, 95% CI: 1.53 to 12.93, p = 0.006).

Six variables (treatment duration, age at initiation, insulin-like growth factor-1 (IGF-1), target height, baseline height, gender) were included in the nomogram model. The model showed good discrimination [area under the curve (AUC) = 0.88 in training set, 95% confidence interval (CI): 0.80 to 0.96; AUC = 0.85 in validation set, 95% CI: 0.69 to 1.00], good calibration, and favorable clinical net benefit.

Conclusion

This study confirms that growth hormone treatment improves growth velocity in children with short stature. A predictive model was established and internally validated. Since treatment duration was the significant predictor and is observed during treatment, the model is more suitable for intra-treatment efficacy evaluation rather than pure pre-treatment decision-making. This model has the potential to support clinicians with individualized dynamic efficacy assessment and subsequent patient management, facilitating the optimization of follow-up treatment regimens.

Publication and source details

Original title: Population characteristics of children with short stature and construction of a predictive model for growth hormone treatment efficacy

Chuanwei Ban; Juan Wang; Qian Zeng; Ping Liu; Xin Lv

Frontiers in Medicine · 2026

* Correspondence: Xin Lv, etyyjyklvxin@163.comCopyright © 2026 Ban, Wang, Zeng, Liu and Lv.2026Ban, Wang, Zeng, Liu and Lvhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This work was supported by [Big Data Program of Jinan Municipal Health Commission], Grant Number [2023-BD-1-09].

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:09:43.077495+00:00

DOI: 10.3389/fmed.2026.1818279 · PMC13384815